Ownership
Private
Employees
~500
Therapeutic Areas
Ophthalmology
Stage
Commercial
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
DeviceSmall moleculeBiologicNon-pharmacological therapy

NVISION Eye Centers General Information

NVISION Eye Centers operates one of the largest networks of ophthalmology clinics and ambulatory surgery centers in the U.S., providing advanced surgical and non-surgical vision correction services. Through its subsidiary NVISION Clinical Research, it conducts over a dozen clinical trials annually in ophthalmic indications[1][5]. The company has performed more than 2.5 million procedures with consistently strong patient outcomes[2].

Contact Information

Primary Industry
Non-Academic Healthcare
Corporate Office
Aliso Viejo, California
USA

Drug Pipeline

No pipeline data available

For full access to NVISION Eye Centers's pipeline data

Book a demo

Key Partnerships

Parkhurst NuVision joint venture in Texas, Multiple affiliate practices nationwide (>50 locations), Collaborations with device manufacturers for clinical trials (not individually named)

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

NVISION Eye Centers Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view NVISION Eye Centers's complete valuation and funding history, request access »

NVISION Eye Centers Financial Metrics